• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Research Brief on 3-(Pyridin-4-yl)propan-1-amine dihydrochloride (CAS: 922189-08-0): Recent Advances and Applications

3-(Pyridin-4-yl)propan-1-amine dihydrochloride (CAS: 922189-08-0) is a chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential as a versatile building block and its biological activity. This research brief aims to provide an overview of the latest studies and applications of this compound, highlighting its role in drug discovery and development.

Recent studies have demonstrated that 3-(Pyridin-4-yl)propan-1-amine dihydrochloride serves as a key intermediate in the synthesis of various pharmacologically active molecules. Its pyridine moiety and amine functionality make it a valuable scaffold for designing compounds with diverse biological activities, including antimicrobial, anticancer, and neurological effects. Researchers have utilized this compound in the development of novel drug candidates targeting specific pathways, such as kinase inhibition and receptor modulation.

One notable application of 3-(Pyridin-4-yl)propan-1-amine dihydrochloride is in the synthesis of small-molecule inhibitors for protein kinases. A 2023 study published in the Journal of Medicinal Chemistry reported the use of this compound as a precursor in the development of selective kinase inhibitors, which showed promising activity against cancer cell lines. The study highlighted the compound's ability to enhance binding affinity and selectivity when incorporated into larger molecular frameworks.

In addition to its role in drug discovery, 3-(Pyridin-4-yl)propan-1-amine dihydrochloride has been investigated for its potential in neuroscience research. A recent preprint article (2024) described its use as a ligand for G protein-coupled receptors (GPCRs) involved in neurotransmitter regulation. The study found that derivatives of this compound exhibited moderate affinity for specific GPCR subtypes, suggesting its utility in designing neuroactive compounds.

The compound's physicochemical properties, including its solubility and stability, have also been the subject of recent investigations. Researchers have developed improved synthetic routes to 3-(Pyridin-4-yl)propan-1-amine dihydrochloride, optimizing yield and purity for pharmaceutical applications. These advancements have facilitated its broader use in high-throughput screening and medicinal chemistry programs.

Looking ahead, the versatility of 3-(Pyridin-4-yl)propan-1-amine dihydrochloride positions it as a valuable tool in chemical biology and drug discovery. Ongoing research is exploring its potential in targeted drug delivery systems and as a component of PROTACs (proteolysis targeting chimeras). Future studies are expected to further elucidate its mechanism of action and expand its applications in therapeutic development.

In conclusion, 3-(Pyridin-4-yl)propan-1-amine dihydrochloride (CAS: 922189-08-0) continues to be a compound of significant interest in pharmaceutical research. Its diverse applications, from kinase inhibition to neuroscience, underscore its importance as a building block in medicinal chemistry. As synthetic methodologies advance and biological studies progress, this compound is likely to play an increasingly prominent role in the development of novel therapeutics.

• 140693-19-2(2-Methyl-3-(pyridin-4-yl)propan-1-amine)
• 114425-75-1(4-(pyridin-4-yl)butan-2-amine)
• 30532-36-6(3-(Pyridin-4-yl)propan-1-amine)
• 84359-21-7(4-Pyridinebutanamine, monohydrochloride)
• 17039-03-1(4-Pyridineethanamine,hydrochloride (1:2))
• 379264-83-2(3-(Pyridin-4-yl)butan-1-amine)
• 116578-57-5(4-Pyridinepropanamine,N-methyl-)
• 62174-83-8(4-(pyridin-4-yl)butan-1-amine)
• 59082-52-9(4-Pyridinepentanamine)
• 6429-12-5(2-(Pyridin-4-yl)ethanamine hydrochloride)